Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025
Market Cap 1 91.84
Change -
Enterprise Value (EV) 1 61.1
Change -
P/E 21.2x
PBR 1.04x
PEG -1.1x
Capitalization / Revenue 1.12x
EV / Revenue 0.74x
EV / EBITDA 7.34x
EV / EBIT 16x
EV / FCF -
FCF Yield -
Dividend per Share 2 -
Rate of return -
EPS 2 1.896
Distribution rate -
Net sales 1 82.35
EBITDA 1 8.319
EBIT 1 3.821
Net income 1 3.947
Net Debt 1 -30.75
Reference price 2 40.24
Nbr of stocks (in thousands) 2,282
Announcement Date 8/26/25
1INR in Million2INR
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 982K
-158.63x13.15x-179.09x-.--% 37.84B
19.4x1.88x10.85x1.04% 23.08B
16.9x1.32x7.52x5.22% 7.19B
303.69x - - - 4.66B
48.22x8.57x30.45x1.08% 2.94B
-31.43x - - -.--% 1.82B
-18.71x - - - 1.86B
33.06x1.65x12.6x1.55% 1.85B
13.09x1.35x5.28x5.78% 1.79B
Average 25.07x 4.65x -18.73x 2.09% 8.3B
Weighted average by Cap. -46.79x 7.78x -85.02x 1.02%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited